纤溶酶联合血栓通治疗老年急性脑梗死临床观察

Clinical observation of Acute Cerebral Infarction in elderly patients with Xianrongmei and Xueshuanatong Injection

目的探讨纤溶酶注射液联合血栓通注射液治疗老年急性脑梗死的临床疗效和安全性观察.方法：选取我院近2年收治的急性脑梗死患者240例,根据治疗方法分为A组（纤溶酶＋血栓通组）、B1组（血栓通注射液组）及B2组（纤溶酶组）各80例,比较3组的临床疗效.结果：A组的显效率（65.0%）及总有效率（92.0%）与B1组、B2组相比明显提高（P〈0.05）,无效率也显著低于B1组、B2组（P〈0.05）,3组均无明显不良反应.结论：纤溶酶联合血栓通注射液治疗老年急性脑梗死有较好疗效,是一种高效、安全的治疗方法.

Objective To discuss the safty and efficacy of Xianrongmei and Xueshuantong Injection in the treatment of acute cerebral infarction in elderly patients .Methods240 elderly cases of acute cerebral infarction in our hospital nearly two years were enrolled in this study.Cases were randomly divided into three groups according to the differenttreatmentgroup A（Xianrongmei and Xueshuanatong Injection）、group B1（Xueshuanatong Injection）、group B2（Xianrongmei Injection）, and compared with the clinical effect. ResultsThe clinical effect was improved in group A which showed significant efficacy（65.0%）and total efficacy（92.0%） compared with group B1 and B2（P〈0.05）,and lowerineffitionciency compared with group B1 and B2（P〈0.05）.There were no obvious adverse effect during treatment in all grops.Conclusion Xianrongmei and Xueshuanatong Injectionhave good curative effect in the treatment of acute cerebral infarction in elderly patients,and which is an effective and safe treatment.